Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Biochim Biophys Acta ; 1431(2): 483-91, 1999 May 18.
Article in English | MEDLINE | ID: mdl-10350623

ABSTRACT

This paper studies the modulation by bradykinin of the ouabain-insensitive Na+-ATPase activity in both renal cortex homogenate and basolateral membrane from proximal tubule. The increase in bradykinin concentration from 10-14 to 10-10 M stimulated the ouabain-insensitive Na+-ATPase activity in cortex homogenates about 2.2-fold, but inhibited the enzyme activity of basolateral membrane preparations by 60%. In both preparations, the maximal effect was obtained with 10-10 M bradykinin. Further increase in the concentration of bradykinin completely abolished these effects. The antagonist of the B2 receptor, Hyp3, completely abolished the effect of 10-10 M bradykinin on the Na+-ATPase activity in the basolateral membrane preparation in a dose-dependent manner, but had no effect on the bradykinin stimulated enzyme activity of the cortex homogenate. Furthermore, in the presence of 10-7 M Hyp3, 10-10 M bradykinin stimulated the Na+-ATPase activity by 45% in the basolateral membrane preparations. The increase in des-Arg9-bradykinin concentration from 10-12 to 10-7 M, an agonist of the B1 receptor, stimulated the Na+-ATPase activity of the cortex homogenates and of the basolateral membrane preparations by 105 and 148%, respectively. In the presence of 25 microM mergetpa, an inhibitor of kininase I, the increase in bradykinin concentration from 10-12 to 10-10 M promoted similar inhibition of the Na+-ATPase activity of both cortex homogenates and basolateral membrane preparations. These results suggest that bradykinin stimulated the Na+-ATPase activity of proximal tubule through the interaction with B1 receptors and inhibited the enzyme through the interaction with B2 receptors. Furthermore, the cortex homogenate expresses a kininase I activity that cleaves bradykinin to des-Arg9-bradykinin.


Subject(s)
Adenosine Triphosphatases/metabolism , Bradykinin/pharmacology , Cation Transport Proteins , Kidney Tubules, Proximal/drug effects , Animals , Cell Membrane/drug effects , Cell Membrane/enzymology , Enzyme Activation/drug effects , Kidney Cortex/drug effects , Kidney Cortex/enzymology , Kidney Tubules, Proximal/enzymology , Lysine Carboxypeptidase , Ouabain , Peptidyl-Dipeptidase A , Receptor, Bradykinin B1 , Receptor, Bradykinin B2 , Receptors, Bradykinin/drug effects , Receptors, Bradykinin/metabolism , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...